Entropy Technologies LP Makes New $248,000 Investment in The Cooper Companies, Inc. (NASDAQ:COO)

Entropy Technologies LP bought a new stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 2,700 shares of the medical device company's stock, valued at approximately $248,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Victory Capital Management Inc. boosted its stake in Cooper Companies by 23.0% during the third quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company's stock worth $435,856,000 after buying an additional 737,726 shares during the period. Highland Capital Management LLC bought a new stake in shares of Cooper Companies in the 4th quarter worth about $4,004,000. Franklin Resources Inc. boosted its stake in shares of Cooper Companies by 194.0% during the 3rd quarter. Franklin Resources Inc. now owns 48,892 shares of the medical device company's stock worth $5,265,000 after purchasing an additional 32,260 shares during the period. Principal Financial Group Inc. grew its holdings in Cooper Companies by 6.6% during the 3rd quarter. Principal Financial Group Inc. now owns 238,305 shares of the medical device company's stock valued at $26,295,000 after purchasing an additional 14,687 shares during the last quarter. Finally, Lecap Asset Management Ltd. raised its position in Cooper Companies by 33.1% in the 4th quarter. Lecap Asset Management Ltd. now owns 11,955 shares of the medical device company's stock worth $1,099,000 after purchasing an additional 2,974 shares during the period. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Down 6.0 %

Shares of COO traded down $5.58 during mid-day trading on Monday, hitting $88.10. The company's stock had a trading volume of 3,052,861 shares, compared to its average volume of 1,320,943. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The company's 50-day moving average is $93.72 and its 200-day moving average is $99.78. The Cooper Companies, Inc. has a 52-week low of $84.76 and a 52-week high of $112.38. The firm has a market capitalization of $17.58 billion, a price-to-earnings ratio of 45.18, a PEG ratio of 2.41 and a beta of 1.00.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping analysts' consensus estimates of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. During the same quarter in the prior year, the business earned $0.87 earnings per share. Cooper Companies's revenue was up 9.8% on a year-over-year basis. On average, equities research analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts have issued reports on COO shares. Citigroup dropped their target price on Cooper Companies from $116.00 to $115.00 and set a "buy" rating for the company in a research report on Friday, December 6th. StockNews.com downgraded Cooper Companies from a "buy" rating to a "hold" rating in a research report on Wednesday, December 11th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a research note on Friday, December 6th. Morgan Stanley lowered their target price on shares of Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating for the company in a research note on Friday, December 6th. Finally, Wells Fargo & Company raised their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an "overweight" rating in a research note on Friday, December 6th. Three research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.